(NBOS) Neuberger Berman Trust - Overview
Etf: Options, Put, Index, Etf
Dividends
| Dividend Yield | 8.16% |
| Yield on Cost 5y | 9.90% |
| Yield CAGR 5y | 10.53% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.9% |
| Relative Tail Risk | 0.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 0.70 |
| Character TTM | |
|---|---|
| Beta | 0.573 |
| Beta Downside | 0.714 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.66% |
| CAGR/Max DD | 0.99 |
Description: NBOS Neuberger Berman Trust December 28, 2025
The Neuberger Berman ETF Trust (NYSE ARCA: NBOS) implements a “collateralized-put” strategy: it writes at-the-money put options on U.S. equity indices-primarily the S&P 500® and related S&P 500® suite indices and ETFs-while simultaneously holding cash or cash equivalents equal to the notional exposure of the written puts. In practice, the notional value of the options written is targeted at roughly 100 % of the fund’s net assets, providing a built-in hedge that limits downside risk to the cash collateral.
Key metrics as of the most recent filing (Q3 2024) show a 12-month annualized return of approximately 3.2 % with a standard deviation of 7.8 %, reflecting the low-volatility profile typical of option-writing ETFs. The fund’s expense ratio stands at 0.55 % and its average daily trading volume is about 150,000 shares, indicating moderate liquidity for institutional and retail investors.
Economic drivers that materially affect NBOS performance include: (1) equity market volatility, measured by the VIX, because higher VIX levels increase option premiums and boost income; (2) the slope of the Treasury yield curve, which influences the cost of financing the cash collateral; and (3) macro-policy shifts (e.g., Fed rate changes) that can alter both equity valuations and option pricing dynamics.
For a deeper, data-driven assessment of NBOS’s risk-adjusted return profile and how its put-writing exposure behaves across market regimes, you may find ValueRay’s interactive analytics platform useful for further research.
What is the price of NBOS shares?
Over the past week, the price has changed by -0.36%, over one month by +1.14%, over three months by +3.68% and over the past year by +11.48%.
Is NBOS a buy, sell or hold?
What are the forecasts/targets for the NBOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.6 | 14.6% |
NBOS Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 437.9m USD (437.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 437.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 437.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.03% (E(437.9m)/V(437.9m) * Re(8.03%) + (debt-free company))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)